Table 1.
Outcomes.
| Hybrid group | Conventionally treated group | p | |
|---|---|---|---|
| Perioperative period | |||
| Death | 2/72 (2.78%) | 5/46 (10.87%) | 0.0696 |
| Paraplegia | 0/72 (0.00%) | 2/46 (4.35%) | 0.0743 |
| Renal failure | 1/72 (1.39%) | 17/46 (36.96%) | <0.0001 |
| Unilateral renal infarction | 5/72 (6.94%) | 4/46 (8.70%) | 0.7267 |
| Intestinal paralysis/necrosis | 1/72 (1.39%) | 4/46 (8.70%) | 0.0546 |
| Respiratory failure | 0/72 (0.00%) | 5/46 (10.87%) | 0.0043 |
| Deep venous thrombosis | 0/72 (0.00%) | 4/46 (8.70%) | 0.0109 |
| Postoperative follow-up | |||
| Death | 5/70 (7.14%) | 4/41 (9.76%) | 0.6264 |
| Unplanned reoperation | 3/70 (4.29%) | 6/41 (14.63%) | 0.0539 |
| Surgical/aneurysm-related deaths | 7/72 (9.72%) | 9/46 (19.57%) | 0.1277 |